Research Topics
| Alexander BystritskySummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trialAlexander Bystritsky
Department of Psychiatry and Biobehavioral Sciences, Anxiety Disorders Program, University of California Los Angeles School of Medicine, Neuropsychiatric Institute and Hospital, 300 UCLA Medical Plaza, Los Angeles, CA 90095, USA
J Clin Psychiatry 65:565-8. 2004..The purpose of this study was to explore the efficacy of adding an atypical antipsychotic, olanzapine, to a serotonin reuptake inhibitor (SRI) in treatment-refractory obsessive-compulsive disorder (OCD)...- Training primary care staff to deliver a computer-assisted cognitive-behavioral therapy program for anxiety disordersRaphael D Rose
Department of Psychology, University of California, Los Angeles, CA 90095 1563, USA
Gen Hosp Psychiatry 33:336-42. 2011..This paper describes the training approach used with primary care staff to deliver an evidence-based computer-assisted cognitive-behavioral therapy (CBT) program for anxiety disorders within a collaborative care treatment delivery model... - Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary careMichelle G Craske
Department of Psychology, University of California at Los Angeles, Los Angeles, CA 90095 1563, USA
Arch Gen Psychiatry 68:378-88. 2011..Anxiety disorders commonly present in primary care, where evidence-based mental health treatments often are unavailable or suboptimally delivered... - Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settingsMichelle G Craske
Department of Psychology, University of California, Los Angeles, California, USA
Depress Anxiety 26:235-42. 2009..The purpose of the current report is to (1) present the structure and format of the computer-assisted CBT program, and (2) to present evidence for acceptance of the program by clinicians and the effectiveness of the program for patients... - CBT intensity and outcome for panic disorder in a primary care settingMichelle G Craske
University of California, Los Angeles, Los Angeles, CA 90095 1563, USA
Behav Ther 37:112-9. 2006..The significance of follow-up booster phone contact is discussed as an index of continued self-management of panic and anxiety following acute treatment... - Regional brain volumes and symptom severity in body dysmorphic disorderJamie D Feusner
Department of Psychiatry, University of California, Los Angeles, CA 90095, United States
Psychiatry Res 172:161-7. 2009..These are in concordance with the involvement of these regions in pathological face processing, which may contribute to the primary symptomatology... - Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting?Michelle G Craske
Department of Psychology, University of California Los Angeles, 405 Holgard Avenue, Los Angeles, CA 90095, USA
Psychol Med 35:1645-54. 2005..Using an as-treated analysis, we evaluated whether the addition of CBT enhanced outcomes for panic disorder relative to medications alone in the primary-care setting... - Treatment for anxiety disorders: Efficacy to effectiveness to implementationMichelle G Craske
University of California, Los Angeles, Department of Psychology, Franz Hall, 405 Hilgard Avenue, Los Angeles, CA 90095, USA
Behav Res Ther 47:931-7. 2009..Future directions for our research include dissemination and implementation of the CALM program, testing potential alternations to the CALM program, and distance delivery of CALM... - Obsessive-compulsive hoarding: symptom severity and response to multimodal treatmentSanjaya Saxena
Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, Los Angeles, Calif 90095, USA
J Clin Psychiatry 63:21-7. 2002.... - Clinical and subthreshold panic disorderAlexander Bystritsky
The Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, California 90095 8346, USA
Depress Anxiety 27:381-9. 2010..The purpose of this study was to add to the accumulating evidence of significant comorbidity and disability associated with subthreshold PD... - A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorderAlexander Bystritsky
Department of Psychiatry, University of California, Los Angeles, CA, USA
Psychopharmacol Bull 41:46-51. 2008..To compare the efficacy and safety of bupropion XL (150 to 300 mg/day) with the selective serotonin reuptake inhibitor escitalopram (10 to 20 mg/day) in outpatients diagnosed with generalized anxiety disorder (GAD)... - Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trialJamie D Feusner
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA
Psychopharmacol Bull 42:81-93. 2009..The objective of this study was to compare the efficacy and safety of memantine in OCD and GAD, and to probe relative effects on OCD and anxiety symptoms... - Assessment of beliefs about psychotropic medication and psychotherapy: development of a measure for patients with anxiety disordersAlexander Bystritsky
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095, USA
Gen Hosp Psychiatry 27:313-8. 2005..Its brevity may make it particularly useful in primary health care settings... - A pilot study of cranial electrotherapy stimulation for generalized anxiety disorderAlexander Bystritsky
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095 6968, USA
J Clin Psychiatry 69:412-7. 2008..The goal of this study was to evaluate the efficacy of CES in alleviating anxiety in patients with DSM-IV-diagnosed GAD... - Presleep attributions about arousal during sleep: nocturnal panicMichelle G Craske
Department of Psychology, University of California, Los Angeles 90095 1563, USA
J Abnorm Psychol 111:53-62. 2002..The findings are consistent with a cognitive model of nocturnal panic attacks... - Treating panic disorder in primary care: a collaborative care interventionMichelle G Craske
Department of Psychology, UCLA, Los Angeles, CA, USA
Gen Hosp Psychiatry 24:148-55. 2002..This description is intended to lay the groundwork for continued research efforts in the extension of efficacious treatments into primary care settings... - A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD)Alexander Bystritsky
Department of Psychiatry, University of California, Los Angeles, CA, USA
J Altern Complement Med 14:175-80. 2008..Whether R. rosea is effective in reducing similar symptoms in clinical samples is unknown. The goal of this pilot study was to evaluate whether R. rosea is effective in reducing symptoms of generalized anxiety disorder (GAD)... - Perceived unmet need for mental health treatment and barriers to care among patients with panic disorderMichelle G Craske
University of California, Los Angeles, CA 90024 1563, USA
Psychiatr Serv 56:988-94. 2005..This study estimated the extent of perceived unmet need for mental health treatment among individuals with panic disorder in primary care settings, investigated the determinants of unmet need, and assessed barriers to care... - A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorderAlexander Bystritsky
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095 6968, USA
J Clin Psychiatry 69:1092-8. 2008..The goal of this pilot study was to evaluate whether functional magnetic resonance imaging (fMRI)-guided rTMS is effective in reducing symptoms of GAD... - Impaired identity recognition of faces with emotional expressions in body dysmorphic disorderJamie Donald Feusner
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA
Psychiatry Res 179:318-23. 2010..This could reflect fundamental abnormalities in visual information processing that are more pronounced for emotional expressions in general, and may relate to their perceptual disturbances... - Visual information processing of faces in body dysmorphic disorderJamie D Feusner
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles, 300 UCLA Medical Plaza, Ste 2345, Los Angeles, CA 90024, USA
Arch Gen Psychiatry 64:1417-25. 2007..This study examines abnormalities in visual information processing in BDD that may underlie clinical symptoms... - Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patientsHolly Hazlett-Stevens
University of California, Los Angeles, CA, USA
Gen Hosp Psychiatry 24:316-21. 2002.... - The effect of attributional processes concerning medication taking on return of fearMark B Powers
Faculty of Social and Behavioral Sciences, University of Amsterdam, Amsterdam, The Netherlands
J Consult Clin Psychol 76:478-90. 2008..These findings highlight the importance of assessing patient attributions regarding the improvements achieved with combined exposure-based and pharmacological treatments for anxiety disorders... - Design of the Coordinated Anxiety Learning and Management (CALM) study: innovations in collaborative care for anxiety disordersGreer Sullivan
South Central VA Mental Illness Research Education and Clinical Center, Central Arkansas Veterans Healthcare System, North Little Rock, AR 72214 1706, USA
Gen Hosp Psychiatry 29:379-87. 2007..Since anxiety disorders are most often treated in primary care, quality improvement interventions, such as the Coordinated Anxiety Learning and Management (CALM) intervention, are needed in primary care... - Moving treatment research from clinical trials to the real worldPeter P Roy-Byrne
Department of Psychiatry and Behavioral Sciences, University of Washington at Harborview Medical Center, Seattle 98014, USA
Psychiatr Serv 54:327-32. 2003.... - Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trialMurray B Stein
Department of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0985, USA
Psychopharmacology (Berl) 177:280-8. 2005..There is a need for new pharmacological treatments for generalized social anxiety disorder (GSAD), which is a common, often disabling condition... - Quality of care for primary care patients with anxiety disordersMurray B Stein
Department of Psychiatry, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093 0985, USA
Am J Psychiatry 161:2230-7. 2004..This study evaluated quality of care for primary care patients with anxiety disorders in university-affiliated outpatient clinics in Los Angeles, San Diego, and Seattle... - Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label studyAnn M Bogan
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
J Clin Psychiatry 66:73-9. 2005..The poorer results at S2 may reflect the large proportion of hoarders or the less intense treatment. Longer, higher dose, large, double-blind, placebo-controlled comparison trials of atypical antipsychotics are needed... - A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorderPeter P Roy-Byrne
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, USA
Arch Gen Psychiatry 62:290-8. 2005.... - Use of herbal medicine in primary care patients with mood and anxiety disordersPeter P Roy-Byrne
Department of Psychiatry and Behavioral Sciences, Harborview Medical Center, University of Washington School of Medicine, Box 359911, 325 9th Ave, Seattle, WA 98104, USA
Psychosomatics 46:117-22. 2005..Use was not associated with receipt of pharmacotherapy or psychotherapy for anxiety or depression... - Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disordersAmy W Wagner
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, Washington 98104 2499, USA
Depress Anxiety 21:99-105. 2005..Treatment adherence may therefore be increased by addressing these beliefs directly... - St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind studyKenneth A Kobak
Dean Foundation for Health Research and Education, Middleton, Wisconsin 53562, USA
Int Clin Psychopharmacol 20:299-304. 2005..9%) and placebo (16.7%) (P=0.905). Only one patient from each group discontinued due to adverse events [sinus infection (St John's wort); confusion (placebo)]. The results fail to support the efficacy of St John's wort for OCD... - Does nocturnal panic represent a more severe form of panic disorder?Michelle G Craske
Department of Psychology, UCLA, 405 Hilgard Ave, Los Angeles, CA 90095-1563. Send reprint requests to Dr. Craske
J Nerv Ment Dis 190:611-8. 2002..The authors conclude that NP may be a specific version of panic disorder characterized by fearful associations with sleep and sleeplike states... - Functional impact and health utility of anxiety disorders in primary care outpatientsMurray B Stein
Department of Psychiatry, University of California San Diego, La Jolla, CA 92093-0985, USA
Med Care 43:1164-70. 2005..Greater awareness of the deleterious impact of anxiety disorders in primary care is warranted... - Fluoxetine treatment and testosterone levelsStewart Bell
Private Practice, Arcadia, CA, USA
Ann Clin Psychiatry 18:19-22. 2006..As decreased testosterone has several negative health effects, we conducted a pilot study investigating the effect of fluoxetine treatment on testosterone levels... - Improving clinical trials: American Society of Clinical Psychopharmacology recommendationsDonald F Klein
New York State Psychiatric Institute and Columbia University, Unit 22, 1051 Riverside Dr, New York, NY 10032, USA
Arch Gen Psychiatry 59:272-8. 2002..The scope of inquiry included identifying means of shifting institutional and regulatory assumptions and processes, even to the point of seeking appropriate national incentives... - The Composite International Diagnostic Interview (CIDI-Auto): problems and remedies for diagnosing panic disorder and social phobiaAdrienne Means-Christensen
University of California, San Diego, CA 92037, USA
Int J Methods Psychiatr Res 12:167-81. 2003..We did not examine the false positive rate for the unmodified or modified CIDI, but this is an important issue that needs to be evaluated in future research...